Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Christine McCluskey | Researchclopedia

Back to researchers

Christine McCluskey

Dana-Farber Cancer Institute ORCID

70

Works

2,508

Citations

13

h-index

13

i10-index

Research Topics

Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Brain Metastases and Treatment

Affiliations

Northwestern University2015–2015

Central DuPage Hospital2015–2015

UMass Memorial Health Care2016–2016

Harvard University2012–2018

University of Pittsburgh2015–2015

Top Works

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin,Annabelle Anandappa,et al.

20181,393 citations

Immunotherapy and Immune Responses

Cancer, Hypoxia, and Metabolism

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Lakshmi Nayak,Annette M. Molinaro,et al.

2020247 citations

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

Patrick Y. Wen,Mehdi Touat,et al.

2019150 citations

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

E. Q. Lee,David A. Reardon,et al.

2015130 citations

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

Andrew D. Norden,Keith L. Ligon,et al.

2014117 citations

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Eudocia Q. Lee,Thomas Kaley,et al.

2015103 citations

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results

Wenya Linda Bi,Lakshmi Nayak,et al.

202187 citations

Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas

Andrew D. Norden,David Schiff,et al.

201460 citations

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma

Eudocia Q. Lee,Dan G. Duda,et al.

201858 citations